183 related articles for article (PubMed ID: 36450898)
1. Disease-associated H58Y mutation affects the nuclear dynamics of human DNA topoisomerase IIβ.
Morotomi-Yano K; Hiromoto Y; Higaki T; Yano KI
Sci Rep; 2022 Nov; 12(1):20627. PubMed ID: 36450898
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21.
Morotomi-Yano K; Yano KI
Sci Rep; 2021 Nov; 11(1):21533. PubMed ID: 34728715
[TBL] [Abstract][Full Text] [Related]
3. Clarifying the Mechanism of Copper(II) α-(N)-Heterocyclic Thiosemicarbazone Complexes on DNA Topoisomerase IIα and IIβ.
Keck JM; Conner JD; Wilson JT; Jiang X; Lisic EC; Deweese JE
Chem Res Toxicol; 2019 Oct; 32(10):2135-2143. PubMed ID: 31512855
[TBL] [Abstract][Full Text] [Related]
4. The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison.
Cowell IG; Ling EM; Swan RL; Brooks MLW; Austin CA
Mol Pharmacol; 2019 Nov; 96(5):562-572. PubMed ID: 31515282
[TBL] [Abstract][Full Text] [Related]
5. ERK2-topoisomerase II regulatory axis is important for gene activation in immediate early genes.
Bunch H; Kim D; Naganuma M; Nakagawa R; Cong A; Jeong J; Ehara H; Vu H; Chang JH; Schellenberg MJ; Sekine SI
Nat Commun; 2023 Dec; 14(1):8341. PubMed ID: 38097570
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
7. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M
Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608
[TBL] [Abstract][Full Text] [Related]
8. A de novo TOP2B variant associated with global developmental delay and autism spectrum disorder.
Hiraide T; Watanabe S; Matsubayashi T; Yanagi K; Nakashima M; Ogata T; Saitsu H
Mol Genet Genomic Med; 2020 Mar; 8(3):e1145. PubMed ID: 31953910
[TBL] [Abstract][Full Text] [Related]
9. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.
Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM
Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049
[TBL] [Abstract][Full Text] [Related]
10. Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
Deng S; Yan T; Jendrny C; Nemecek A; Vincetic M; Gödtel-Armbrust U; Wojnowski L
BMC Cancer; 2014 Nov; 14():842. PubMed ID: 25406834
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive structural analysis of the ATPase domain of human DNA topoisomerase II beta bound to AMPPNP, ADP, and the bisdioxopiperazine, ICRF193.
Ling EM; Baslé A; Cowell IG; van den Berg B; Blower TR; Austin CA
Structure; 2022 Aug; 30(8):1129-1145.e3. PubMed ID: 35660158
[TBL] [Abstract][Full Text] [Related]
12. The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1.
Smith KA; Cowell IG; Zhang Y; Sondka Z; Austin CA
Genes Chromosomes Cancer; 2014 Feb; 53(2):117-28. PubMed ID: 24327541
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide prediction of topoisomerase IIβ binding by architectural factors and chromatin accessibility.
Martínez-García PM; García-Torres M; Divina F; Terrón-Bautista J; Delgado-Sainz I; Gómez-Vela F; Cortés-Ledesma F
PLoS Comput Biol; 2021 Jan; 17(1):e1007814. PubMed ID: 33465072
[TBL] [Abstract][Full Text] [Related]
14. NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15).
Nebral K; Schmidt HH; Haas OA; Strehl S
Clin Cancer Res; 2005 Sep; 11(18):6489-94. PubMed ID: 16166424
[TBL] [Abstract][Full Text] [Related]
15. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
16. To Break or Not to Break: The Role of TOP2B in Transcription.
Cowell IG; Casement JW; Austin CA
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834253
[TBL] [Abstract][Full Text] [Related]
17. RAD54L2-mediated DNA damage avoidance pathway specifically preserves genome integrity in response to topoisomerase 2 poisons.
Zhang H; Xiong Y; Sun Y; Park JM; Su D; Feng X; Keast S; Tang M; Huang M; Wang C; Srivastava M; Yang C; Zhu D; Chen Z; Li S; Yin L; Pommier Y; Chen J
Sci Adv; 2023 Dec; 9(49):eadi6681. PubMed ID: 38055811
[TBL] [Abstract][Full Text] [Related]
18. A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent Complexes.
Swan RL; Cowell IG; Austin CA
Mol Pharmacol; 2021 Jul; 100(1):57-62. PubMed ID: 33941661
[TBL] [Abstract][Full Text] [Related]
19. Topological regulation of the estrogen transcriptional response by ZATT-mediated inhibition of TOP2B activity.
Terrón-Bautista J; Martínez-Sánchez MDM; López-Hernández L; Vadusevan AA; García-Domínguez M; Williams RS; Aguilera A; Millán-Zambrano G; Cortés-Ledesma F
bioRxiv; 2024 Jan; ():. PubMed ID: 38328138
[TBL] [Abstract][Full Text] [Related]
20. TOP2B: The First Thirty Years.
Austin CA; Lee KC; Swan RL; Khazeem MM; Manville CM; Cridland P; Treumann A; Porter A; Morris NJ; Cowell IG
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
